Literature DB >> 11345278

Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results.

S L Szeinbach1, J H Barnes, T J Sullivan, P B Williams.   

Abstract

BACKGROUND: Accurate and reliable evaluation of the presence or absence of allergen-specific IgE is important in the differential diagnosis of allergic disease. A variety of different commercial tests are available for this purpose. There are few data available to judge how the results of these different tests compare with one another in everyday use.
OBJECTIVE: To examine prospectively the extent of comparability among specific IgE results from different laboratories.
METHODS: Six diagnostic laboratories employing five different methods to assay specific IgE were selected. Aliquots from 26 serum samples that contained variable levels of IgE specific to 17 common aeroallergens were sent in triplicate to each study laboratory during a 6-week time period. Results were reported numerically and by class scores and then compared by examining their concordance using Kendall's W nonparametric statistical test. In addition, cut-off values were compared by a best agreement analysis using reported results. Reproducibility was determined using precision profiles based upon the coefficient of variation among triplicates for each allergen across the range of reported results.
RESULTS: In all, 7,813 tests were analyzed. Concordance among different assays in commercial use with one exception was not good. This was particularly true around the cut-off region where most assays demonstrated high imprecision. The Pharmacia CAP System used by two different laboratories demonstrated highly comparable results with good precision. Some assays were reproducible but not accurate. Others were neither reproducible nor accurate.
CONCLUSIONS: The results of this study indicate that not all commercial laboratories/assays for specific IgE provide reproducible and accurate data. Significant potential for misdiagnosis was detected for some reported results. Methods were identified that do give sensitive, accurate, and reproducible results.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345278     DOI: 10.1016/S1081-1206(10)62481-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

1.  Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies.

Authors:  Federico C F Calboli; David G Cox; Julie E Buring; J Michael Gaziano; Jing Ma; Meir Stampfer; Walter C Willett; Shelley S Tworoger; David J Hunter; Carlos A Camargo; Dominique S Michaud
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma.

Authors:  Mi Zhou; Joseph L Wiemels; Paige M Bracci; Margaret R Wrensch; Lucie S McCoy; Terri Rice; Jennette D Sison; Joseph S Patoka; John K Wiencke
Journal:  Cancer Res       Date:  2010-08-18       Impact factor: 12.701

3.  Analysis of the Serum Profile of Cytokines Involved in the T-Helper Cell Type 17 Immune Response Pathway in Atopic Children with Food Allergy.

Authors:  Kacper Packi; Joanna Matysiak; Sylwia Klimczak; Eliza Matuszewska; Anna Bręborowicz; Dagmara Pietkiewicz; Jan Matysiak
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

4.  Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects.

Authors:  Xiaoyi Ning; Yun Kuang; Shuwei Zhao; Wenjing Hou; Guoping Yang; Xuerui Zhu; Ruiling Liu; Jie Huang
Journal:  J Asthma Allergy       Date:  2020-10-13

5.  IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.

Authors:  Joseph L Wiemels; David Wilson; Chirag Patil; Joseph Patoka; Lucie McCoy; Terri Rice; Judith Schwartzbaum; Amy Heimberger; John H Sampson; Susan Chang; Michael Prados; John K Wiencke; Margaret Wrensch
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

6.  Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.

Authors:  Mi Zhou; Paige M Bracci; Lucie S McCoy; George Hsuang; Joseph L Wiemels; Terri Rice; Shichun Zheng; Karl T Kelsey; Margaret R Wrensch; John K Wiencke
Journal:  Int J Cancer       Date:  2015-02-02       Impact factor: 7.316

7.  Comparison of the ImmunoCAP Assay and AdvanSure™ AlloScreen Advanced Multiplex Specific IgE Detection Assay.

Authors:  Kyung Hee Park; Jongsun Lee; Sang Chul Lee; Young Woong Son; Da Woon Sim; Jae Hyun Lee; Jung Won Park
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

8.  Accuracy of immunoblotting assay for detection of specific IgE compared with ImmunoCAP in allergic patients.

Authors:  Raheleh Shokouhi Shoormasti; Mohammad Reza Fazlollahi; Anoshirvan Kazemnejad; Masoud Movahedi; Behnoosh Tayebi; Zahra Yazdanyar; Zakieh Azadi; Zahra Pourpak; Mostafa Moin
Journal:  Electron Physician       Date:  2018-02-25

9.  Sensitivity and specificity of standardised allergen extracts in skin prick test for diagnoses of IgE-mediated respiratory allergies.

Authors:  Nicola Wagner; Michael Rudert
Journal:  Clin Transl Allergy       Date:  2019-02-18       Impact factor: 5.871

10.  Comparison of an automated microfluidic immunoassay technology (BioIC, lab-on-chips) and ImmunoCAP assay. Lab-on-chips as a tool for specific IgE (sIgE) detection.

Authors:  Izabela Szymczak-Pajor; Rafal Pawliczak
Journal:  Postepy Dermatol Alergol       Date:  2020-03-09       Impact factor: 1.837

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.